IFI-M · HSB Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-00927 // MULTI-AXIS · IFI-M

HSB Tri-Axis Dominant-Primary Series I-BL

Capsicum chinense

Habanero

Tier IHSB Tri-Axis Dominant-Primary Series

Target Trait

1.1×

fold-change

Heat-dominant tri-axis S+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-00927

Genomic Edits

6

GC Content

46%

Construct Length

4,330 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPV1 + TAS1R2/TAS1R3 + TAS2R38 (suppression)

IFI Score

110

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HSB pathway operation
  • Cross-pathway regulatory circuit for heat-dominant HSB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, TAS1R2/TAS1R3, and TAS2R38 (suppression) pathways simultaneously engineeredHeat-dominant tri-axis expression strategy (HSB) with cross-pathway flux managementBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier I HSB triple-axis construct for advanced multi-modal sensory architecture combining heat, sweet, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities